121
Views
6
CrossRef citations to date
0
Altmetric
Articles

Identification of Chemo and Radio-Resistant Sub-Population of Stem Cells in Human Cervical Cancer HeLa Cells

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 661-674 | Received 12 Oct 2020, Accepted 15 May 2021, Published online: 08 Jul 2021
 

Abstract

Background

Cervical cancer ranks the second female malignancy after breast cancer. Cancer stem cells (CSCs) are hard to be eradicated, so can recur. We aim to isolate and characterize CSCs from HeLa cells.

Methods

These cells express clusters of differentiation (CDs), 44 and 24, to be sorted by fluorescence-activated cell sorting (FACS).

Results

CD44+CD24+ cells showed potential to form spheres, tumorigenicity, stemness genes and higher resistance to cisplatin, X-ray.

Conclusion

CD44+CD24+ HeLa cells hold characteristics of CSCs, in vitro, in vivo studies, suggesting that targeting may lead to screening of new anti-cancer therapies.

Acknowledgments

We are grateful to Ms. Etsuko Furuichi and Mr. Masahiko Kawahara for their technical support. 

Ethics approval

All the work was reviewed by the Research Committee of Regenerative Medicine, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.

Author contributions

MF carried out most of the research, performed statistical analysis and wrote the paper draft. CK participated in RT-PCR and colony assay. MO participated in cell sorting. TY participated in staining and performed the in vivo experiments. MAZ, MF, KZ, NM and TN were involved in drafting the manuscript and conceived the study and design research. NM revised the whole laboratory results, prepared EndNoting of text and references, was in charge of submission, review and comments and correspondence. All authors read and approved the final manuscript. AMM helped in the revision of the manuscript for submission.

Disclosure statement

There are no conflicts of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.